Heart failure is a leading cause of mortality and hospitalization worldwide. Cardiac fibrosis,
resulting from the excessive deposition of collagen fibers, is a common feature across the …

The approval of new heart failure (HF) therapies has slowed over the past two decades in
part due to the high costs of conducting large randomized clinical trials that are needed to …

Fibrosis is defined by the excessive accumulation of extracellular matrix (ECM) and
constitutes a central pathophysiological process that underlies tissue dysfunction, across …

Cardiac fibrosis constitutes irreversible necrosis of the heart muscle as a consequence of
different acute (myocardial infarction) or chronic (diabetes, hypertension,…) diseases but …

Schematic diagram listing the established confounders of cardioprotection and
characterizing in more detail the features of the novel confounder 'primordial non …

Mitochondrial electron transport chain (ETC) complexes partition between free complexes
and quaternary assemblies known as supercomplexes (SCs). However, the physiological …

The aim of this study was to determine the discriminative value of irisin for acutely
decompensated heart failure (ADHF) in type 2 diabetes mellitus (T2DM) patients with …

In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

Аннотация Обзор посвящен анализу результатов исследований эпидемиологии,
механизмов развития, методов диагностики и лечения больных сердечной …

Circulating circular RNAs (circRNAs) are emerging as novel biomarkers for cardiovascular
diseases (CVDs). Machine learning can provide optimal predictions on the diagnosis of …